It consisted of three national surveys and 13 pan-Canadian research projects targeting 15 priority neurological conditions, including Alzheimer's disease (AD) and related dementias. One of the projects consisted of carefully performed systematic reviews (and, where possible, meta-analyses) of incidence and prevalence studies of these priority conditions.
The National Population Health Study of Neurological Conditions (NPHSNC) was an ambitious program of research funded by the Government of Canada designed to improve our understanding of neurological conditions and their impact on Canadians. 1, 2 It consisted of three national surveys and 13 pan-Canadian research projects targeting 15 priority neurological conditions, including Alzheimer's disease (AD) and related dementias. One of the projects consisted of carefully performed systematic reviews (and, where possible, meta-analyses) of incidence and prevalence studies of these priority conditions. 3 In this supplement, we report on the results of this work on dementia overall and for the more common underlying neurodegenerative causes (i.e., dementia due to AD, dementia with Lewy bodies [DLB], frontotemporal dementia [FTD]). Table 1 provides a summary of the key findings that are elaborated on in the papers in this supplement. Table 2 provides definitions of the epidemiological estimates for prevalence and incidence reported in these papers.
Accurate information on the epidemiology of dementia is important for planning services to deal with the needs of those suffering from the condition as well as those of their family and caregivers. In projecting future demand, we must determine if incidence and/or prevalence is changing or remaining much as before in the population we serve. Otherwise, there is a risk of either under-or overestimating the resources required if our projections are based on dated information or figures imported from other nations. Finding evidence of true variation over time or across regions suggests that future rates are potentially changeable. Interventions directed at modifiable risk factors in future cohorts could lead to significant delays in onset if not outright prevention of age-related dementia. The need for accurate and timely information underscores the necessity of continuing to do epidemiological studies of these conditions.
As noted in the individual papers, there are a number of methodological issues with the incidence and prevalence studies done to date that detract from our ability to obtain accurate estimates that, among other things, can be used to look for variability across time and regions. While some of these methodological challenges are unique to the specific conditions reviewed, a number are common to all dementias and other neurological conditions. 3 Future studies must use validated diagnostic criteria and approaches to case ascertainment. One particular challenge will be determining how to implement new diagnostic criteria in a manner that ensures that we have data comparable to those from studies using older ones. Unless driven by a particular study design requirement, investigators should target similarly aged populations of the two sexes, collect standardized data and report results in a consistent manner. Use of the recently published standards of reporting of neurological disorders (STROND) checklist, a guideline for incidence and prevalence studies of these conditions, should enhance the quality of future publications. 4 Notwithstanding these limitations, this supplement summarizes our current understanding of the epidemiology of AD and related disorders. Our work was guided by recommended methodology. 5 Literature searches identified a total of 16,066 citations, with 707 papers selected for full-text reviews conducted by 11 reviewers using a standardized approach. Abstracted data were analyzed, with the findings discussed internally as to what they indicated before conclusions were reached. On behalf of our study team, we are delighted to present the results. 
